United Kingdom

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

15 Dec 2017
Change (% chg)

$-0.20 (-2.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Immucell Q3 loss per share $0.07
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Immucell Corp ::Immucell announces financial results for third quarter of 2017.Q3 loss per share $0.07.Immucell - ‍during 3-month period ended Sept 30, 2017, total product sales were just over $2 million versus just under $2 million during same quarter of 2016​.  Full Article

Immucell Q4 sales fell 18 pct
Thursday, 9 Feb 2017 

Immucell Corp : Immucell announces preliminary 2016 financial results .Q4 sales fell 18 percent to $2.2 million.  Full Article

Immucell Corp sees FDA approval for Mast Out in 2019
Tuesday, 11 Oct 2016 

Immucell Corp :Immucell Corp - U.S. FDA approval for co's product Mast Out anticipated in 2019, allowing for two, six-month reviews of cmc technical section by FDA.  Full Article

Immucell posts Q2 earnings per share $0.00
Thursday, 11 Aug 2016 

Immucell Corp : Immucell announces second quarter 2016 financial results . Q2 sales rose 21 percent to $2.4 million .Q2 earnings per share $0.00.  Full Article

Immucell Q1 earnings per share $0.11
Wednesday, 11 May 2016 

Immucell Corp : Immucell announces first quarter 2016 financial results . Q1 earnings per share $0.11 .Q1 sales fell 3.7 percent to $3.0 million.  Full Article

ImmuCell Corp announces pricing of $5.9 mln public offering of common shares
Friday, 29 Jan 2016 

ImmuCell Corp:Announces pricing of $5.9 million public offering of common shares.Says public offering of 1.1 million common shares priced at $5.25 per share.  Full Article

ImmuCell Corp acquires certain assets from Minnesota Firm
Wednesday, 6 Jan 2016 

ImmuCell Corp:Acquires certain assets from Minnesota Firm.Purchase also includes certain other related private-label products.Total purchase price is expected to approximate $350,000 to $550,000.  Full Article

BRIEF-Immucell Q3 loss per share $0.07

* Immucell announces financial results for third quarter of 2017

No consensus analysis data available.